工作经历： 1984年—1991年：第四军医大学西京医院心脏外科工作 1991年—1999年：第一军医大学大学南方医院胸心外科工作 1999年—2001年：广州市第一人民医院胸外科工作 2001年—至 今： 中山大学肿瘤医院工作 2006年—2010年：中山大学肿瘤医院胸科副主任 2010年—至 今： 中山大学肿瘤医院胸科主任

1．胸部肿瘤的外科手术治疗 2．肿瘤标本库及肿瘤信息平台建设 3．肿瘤个体化治疗的分子标志物筛选及临床应用 4．生物组织工程技术在胸外科的应用 5．人工食管的构建及应用 6．人工胸壁的构建及应用于胸壁缺损的修复重建

1. Zhang LJ, Wang WP, Li WY, et al. A new alternative for bony chest wall reconstruction using biomaterial artificial ribs and pleura: animal experiment and clinical application. Eur J Cardiothorac Surg. 2010, OCT; 40(4):939-947. 　　2. Dai Y, Long H, Lin P, Fu JH, Zhang LJ, Zhu ZH, Zhang X, Rong TH, Su XD. Impact of the number of resected and involved lymph nodes on the outcome in patients with stage II non-small cell lung cancer. 中华肿瘤杂志. 2010 jun; 32(6):436-440. 　　3. Liu WL, Guo XZ, Zhang LJ, Wang JY, Zhang G, Guan S, Chen YM, Kong QL, Xu LH, Liu MZ, Song LB, Zeng MS. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC cancer. 2010 Sep; 10:467. 　　4. Dai Y, Su XD, Long H, Lin P, Fu JH, Zhang LJ, Wang X, Wen ZS, Zhu ZH, Zhang X, Rong TH. Survival analysis of 220 patients with completely resected stage II non-small cell lung cancer. Chin J Cancer. 2010 May; 29(5):538-544. 　　5. Xie MR, Zhang X, Lin P, Lin YB, Rong TH, Zhang LJ, Wen ZS, Li XD. Short and lon-term outcomes of neoadjuvant chemotherapy for local advanced esophageal carcinoma. Zhonghua Yi Xue Za Zhi. 2009 Nov; 89(41):2906-2909. 　　6. He LR, Zhao HY, Li BK, Zhang LJ, Liu MZ, Kung HF, Bian XW, Zeng YX, Xie D. Overexpression of AIB1 negatively affects survival of surgical resected non-small cell lung cancer patients. Ann Oncol. 2010 Aug; 21(8): 1675-1681. 　　7. Yu H, Zhang SY, Wang X, Xie ZM, Wang JY, Li Y, Xie X, Zhou JL, Zhang LJ, Fu JH. Evaluation of scalene lymph node or contralateral mediastinum biopsy during mediastinoscopy for non-small cell lung cancer. 中华肿瘤杂志. 2009 Oct; 31(10):780-782. 　　8. He LR, Liu MZ, Li BK, Jia WH, Zhang Y, Liao YJ, Chen YC, Zhang LJ, Guan XY, Zeng YX, Kung HF, Xie D. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Int J Cancer. 2010 Jul 1; 127(1):138-147. 　　9. Zhang DK, Su XD, Lin P, Long H, Fu JH, Zhang LJ, Ma GW, Rong TH. Clinical analysis of 22 cases of esophageal adenosquamous carcinoma. 中华肿瘤杂志. 2009 Apr; 31(4):302-304. 　　10. Zhu ZH, Sun BY, Ma Y, Shao JY, Long H, Zhang X, Fu JH, Zhang LJ, Su XD, Wu QL, Ling P, Chen M, Xie ZM, Hu Y, Rong TH, Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small cell lung cancer. J Clin Oncol. 2009 Mar 1; 27(7): 1091-1099. 　　11. Zhang DK, Su XD, Long H, Lin P, Fu JH, Zhang LJ, Ma GW, Zhu ZH, Dai Y, Rong TH. Surgical treatment and prognosis in patients with squamous cell carcinoma of the thoracic esophagus. 中华外科杂志 2008 Sep; 46(17):1333-1336. 　　12. Su XD, Long H, Wang X, Fu JH, He JH, Lin P, Zhang LJ, Ma GW. Impact of visceral pleural invasion on the prognosis of stage Ib non-small cell lung cancer. 中华肿瘤杂志. 2008 May; 30(5):368-371. 　　13. Su XD, Wang X, Rong TH, Long H, Fu JH, Lin P, Zhang LJ, Wang SY, Wen ZS, Ma GW. Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer. 中华外科杂志2007 Nov 15; 45(22):1543-1545. 　　14. Deng YJ, Rong TH, Zhang LJ, Su XD, Lin ZC, Situ DR. Influence of unexpected simultaneous splenectomy on postoperative complications and prognosis of patients undergoing radical esophagectomy for esophageal carcinoma. Ai Zheng. 2007 Sep; 26(9): 983-986. 　　15. Li BJ, Wang JY, Huang XP, Zhang LJ, Long H, Yang MT, Rong TH. Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient. 中华肿瘤杂志. 2006 Oct; 28(10):766-769. 　　16. Lin ZC, Long H, Rong TH, Yang MT, Huang ZF, Lin P, Zhang LJ, Li XD. Surgical treatment efficacy of bronchioloalveolar carcinoma: a retrospective analysis of 130 patients. Ai Zheng. 2006 Sep: 25(9):1123-1126. 　　17. Zhang PY, Li BJ, Su XD, Wen ZS, Zhao JM, Zhang LJ, Long H, Rong TH. In vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T. Ai Zheng. 2006 Apr; 25(4): 456-60. 　　18. Huang XP,Rong TH, Wang JY, Tang YQ, Li BJ, Xu DR, Zhao MQ, Zhang LJ, Fang Y, Su XD, Liang QW. Negative implication of C-MYC as an amplification target in esophageal cancer. Cancer Genet Cytogenet. 2006 Feb; 165(1): 20-24.